Distinct systemic immune networks define severe vs. mild COVID-19 in hematologic and solid cancer patients

Distinct systemic immune networks define severe vs. mild COVID-19 in hematologic and solid cancer patients

IntroductionThe COVID-19 pandemic, caused by the coronavirus SARS-CoV-2, has impacted health across all sectors of society. A cytokine-release syndrome, combined with an inefficient response of innate immune cells to directly combat the virus, characterizes the severe form of COVID-19. While immune...

Full description

Bibliographic Details
Main Authors: Flávio Pignataro-Oshiro, Amanda B. Figueiredo, Nayane A. L. Galdino, Katia L. P. Morais, Walderez O. Dutra, Bianca Grassi de Miranda Silva, Diego Feriani, Flávia de Azevedo Abrantes, Ivan Leonardo Avelino França e Silva, Jayr Schmidt Filho, Juliana Valéria de Souza Framil, Marcelle Goldner Cesca, Rachel Simões Pimenta Riechelmann, Marjorie V. Batista, Kenneth J. Gollob
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Immunology
Subjects:
SARS-CoV-2
COVID-19
cancer
systemic immune profile
disease severity prediction
cytokine-release syndrome
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1052104/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1052104/full

Similar Items